AdNRGM; VDEPT + GMCSF in locally recurrent prostate cancer

• Research type

  Research Study

• Full title

  A Phase I Clinical Trial of a replication defective type 5 adenovirus vector expressing nitroreductase and GMCSF (AdNRGM) given via trans-perineal, template-guided, intra-prostatic injection, followed by intravenous CB1954, in patients with locally relapsed Prostate Cancer

• IRAS ID

  45807

• Contact name

  Prashant Patel

• Contact email

  p.patel@bham.ac.uk

• Eudract number

  2007-007041-13

• ISRCTN Number

  N/A

• Clinicaltrials.gov Identifier

  N/A

• REC name

  South Central - Oxford A Research Ethics Committee

• REC reference

  12/SC/0660

• Date of REC Opinion

  7 Jan 2013

• REC opinion

  Further Information Favourable Opinion